THYQUIDITY
Peaklevothyroxine sodium
NDAORALSOLUTION
Approved
Nov 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
3
Clinical Trials (3)
Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form
Started Jun 2019
72 enrolled
Healthy
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
Started Jul 2018
66 enrolled
Hypothyroidism;Postablative
Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation
Started Jul 2013
101 enrolled
Hypothyroidism
Loss of Exclusivity
LOE Date
Aug 6, 2031
65 months away
Patent Expiry
Aug 6, 2031
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 9050307 | Aug 6, 2031 | Product | — |